Vascular endothelial cells act as antigen-presenting cells in the lung
allograft and stimulate alloreactive host lymphocytes. Activated lymp
hocytes and cytokines can induce expression of leukocyte-endothelial a
dhesion molecules that facilitate invasion of tbe allograft by circula
ting leukocytes. To define the role of endothelial HLA class II antige
n and adhesion molecule expression in lung allograft rejection, we pro
spectively analyzed endothelial expression of HLA class II, E-selectin
, and intercellular adhesion molecule-1 (ICAM-1) antigens in 52 transb
ronchial biopsy specimens from 24 lung allograft recipients as compare
d to normal control subjects. Thirty-one of 52 specimens showed histol
ogic rejection and 8 of 24, patients developed histologic obliterative
bronchiolitis (OB) by the end of the study period. Increased expressi
on of HLA class II antigen was seen in 32 of 52 (62%) lung allograft s
pecimens, but increased expression did not correlate with acute reject
ion or OB. In contrast, E-selectin expression was seen in 30 of 52 (58
%) biopsy specimens and was associated with acute rejection (p<0.005)
and with the development of OB (p<0.05). Increased expression of ICAM-
1 was seen in only 18 of 52 (35%) biopsy specimens and did not correla
te with acute rejection or OB, These data suggest that E-selectin expr
ession may be a tissue marker of acute and chronic lung rejection poss
ibly by promoting leukocyte adhesion to the allograft endothelium. The
high levels of endothelial HLA class II expression may reflect long-t
erm antigenic stimulation of the allograft even in the absence of reje
ction.